Tackling the complications of childhood cancer treatment

June 28, 2013
Tackling the complications of childhood cancer treatment
Credit: Shutterstock

While the diagnosis of any child or teenager with cancer is extremely traumatic, there have been huge advances in treatment; the five-year survival rate is now 80 percent in developed countries. With more young people surviving the disease, it has become increasingly important to understand the impacts treatment could have in later life. A team of European researchers is working with young survivors to establish the facts.

Approximately 1 in 750 is now a childhood cancer survivor. Of these, it is estimated that 300,000 to 500,000 live in Europe. Using data from European registries, researchers are following around 80,000 survivors of childhood and adolescent cancer, making this the largest study of its kind to date.

The project is known as PanCareSurFup ('PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies') and has received almost EUR 6 million in EU funding.

The team is focusing in particular on three affecting young : , subsequent cancers and causes of 'late deaths' - those occurring more than five years after treatment ends.

The type and severity of late effects depends mainly on the original cancer, the age at treatment and the type and dose of treatment. To understand the risks better, the team will estimate the received by the various organs of survivors. Much of the damage can be traced back to organs and tissues that are still growing being exposed to radiation.

After adding this information to the new database, the team will then calculate the risk of specific outcomes. Control studies will be carried out, with researchers checking their risk estimates against information on lifestyle and employment.

The results will be used to draw up guidelines for care. Ultimately this should lead to better long-term health for all young cancer survivors. Survivors and doctors will be able to identify and treat side-effects at an early stage, while scientists will seek to design new types of treatment that are less likely to cause severe or disabling complications for young cancer survivors, who still have their whole lives ahead of them.

PanCareSurFup runs from 2011 to 2016. But the research will not end with the project. The consortium was created from members of PanCare, a pan-European network for long-term survivors of childhood and adolescent cancer. Post-2016, the network will expand into other areas, such as fertility, hearing impairment and quality of survivorship, building on the results and collaboration forged within the EU-funded project.

Explore further: GW Cancer Institute publishes research on challenges faced by adolescent cancer survivors

More information: cordis.europa.eu/projects/rcn/97692_en.html

Related Stories

GW Cancer Institute publishes research on challenges faced by adolescent cancer survivors

April 26, 2013
New research out of the George Washington University Cancer Institute (GWCI) focuses on the difficulties of transitioning to adulthood while dealing with the long-term and late effects of cancer and its treatment. The study ...

Childhood cancer survivors found to have significant undiagnosed disease as adults

June 21, 2013
St. Jude Children's Research Hospital has found that childhood cancer survivors overwhelmingly experience a significant amount of undiagnosed, serious disease through their adult years, establishing the importance of proactive, ...

Guidelines updated for young CA survivors' fertility follow-up

February 5, 2013
(HealthDay)—Current recommendations for the assessment and management of female reproductive complications following treatment of cancers in childhood, adolescence, and young adulthood have been updated, according to a ...

Young cancer survivors often forgo medical care due to costs

September 24, 2012
Many survivors of adolescent and young adult cancers avoid routine medical care because it's too expensive, despite the fact that most have health insurance. That is the conclusion of a new study published early online in ...

Survived cancer? Now look out for cardiovascular risks

April 16, 2013
Many people survive their cancers, but end up dying of cardiovascular disease (CVD). New research from Wake Forest Baptist Medical Center finds that CVD risk factors may be overlooked during survivorship care.

Cancer survivors battle with the blues

May 16, 2013
Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That's according to a new study, by Floortje Mols and colleagues, from Tilburg ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.